Flublok

BIOLOGICAL4 trials

Sponsors

Protein Sciences Corporation, University of Rochester, Centers for Disease Control and Prevention, The University of Hong Kong

Conditions

InfluenzaInfluenza, Human

Phase 3

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

CompletedNCT01825200

Protein Sciences CorporationInfluenza

Start: 2013-03-31End: 2013-05-31Updated: 2015-02-18

Phase 4

Comparison of Three Licensed Influenza Vaccines

CompletedNCT03068949

University of RochesterInfluenza

Start: 2015-10-28End: 2021-06-30Updated: 2021-11-30

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

CompletedNCT03722589

Centers for Disease Control and PreventionInfluenza

Start: 2018-09-12End: 2020-07-31Updated: 2024-07-22

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures

The University of Hong KongInfluenza, Human

Start: 2020-10-05End: 2025-12-31Updated: 2023-12-11

Related Papers

Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial

Clinical Infectious Diseases2024-07-196 citations

Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.

2024-01-0414 citations

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial

Clinical Infectious Diseases2022-08-2914 citations

Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized Open-Label Trial

Clinical Infectious Diseases2021-06-2441 citations

Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein–Based Influenza Vaccines During the 2017–2018 Season

Clinical Infectious Diseases2019-10-0447 citations

Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.

2015-11-0121 citations